Skip to content

An exploratory study of the effect of wuzhi jiaonang on the intestinal flora of overweight and obese patients

An exploratory study of the effect of wuzhi jiaonang on the intestinal flora of overweight and obese patients

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092681
Enrollment
Unknown
Registered
2024-11-21
Start date
2024-12-01
Completion date
Unknown
Last updated
2025-07-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Interventions

Wuzhi jiaonang Experimental group:Behavioural intervention for 4 weeks, with concomitant administration of wuzhi jiaonang (4 capsules/dose, 3 times a day).

Sponsors

Shanghai Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. Aged 18-60 years old; 2. Meeting the diagnostic criteria for overweight or obesity, with a BMI = 24 kg/m2; 3. Not allergic to Schisandrae Chinensis Fructus fractions; 4. Good treatment compliance and cooperation in completing the study; 5. Willingness to participate in this study and sign an informed consent form. All of the above conditions must be met to be included in this study.

Exclusion criteria

Exclusion criteria: 1. Patients with secondary or medical obesity, such as obesity caused by abnormal function of gonadal axis, adrenal axis, thyroid axis, and obesity caused by glucocorticoids and other medications; 2. Pregnant and breastfeeding women; 3. Patients with severe cardiovascular and cerebral vascular diseases, or hepatic and renal failure; 4. Patients with severe infection/ketosis within the past 3 months; 5. Patients who have undergone bariatric surgery in the past 1 year; 6. Patients who have lost more than 10 % of their body weight in the past 3 months; 7. Other conditions that are not suitable for inclusion. If any of the above conditions exists, it is not allowed to be included in this study.

Design outcomes

Primary

MeasureTime frame
Changes in the BSH enzyme-associated flora of Lactobacillus et al.;GCA and other conjugated bile acids;Decrease in body weight,;Decrease in body mass index;Body fat mass;

Secondary

MeasureTime frame
liver function;Triglyceride;Total Cholesterol;Low-Density Lipoprotein Cholesterol;

Countries

China

Contacts

Public ContactTao Feng

Shanghai Traditional Chinese Medicine Hospital

taofeng@shutcm.edu.cn+86 130 9310 8478

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026